Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Metastasis
×
L19-IL2 immunocytokine
×
Clear all
Filters
3
NCT03705403
2025-01-30
IMMUNOSABR2
Maastricht University Medical Center
Phase 2
Terminated
88 enrolled